Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
59.38
+0.17 (0.29%)
At close: Jun 12, 2026, 4:00 PM EDT
60.18
+0.80 (1.35%)
After-hours: Jun 12, 2026, 6:35 PM EDT
Nektar Therapeutics Employees
Nektar Therapeutics had 63 employees as of December 31, 2025. The number of employees increased by 2 or 3.28% compared to the previous year.
Employees
63
Change (1Y)
2
Growth (1Y)
3.28%
Revenue / Employee
$883,063
Profits / Employee
-$2,509,492
Market Cap
2.01B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 63 | 2 | 3.28% |
| Dec 31, 2024 | 61 | -76 | -55.47% |
| Dec 31, 2023 | 137 | -79 | -36.57% |
| Dec 31, 2022 | 216 | -524 | -70.81% |
| Dec 31, 2021 | 740 | 22 | 3.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| ADMA Biologics | 647 |
| Lakefront Biotherapeutics NV | 558 |
| Vericel | 398 |
| Ocular Therapeutix | 325 |
| Harmony Biosciences Holdings | 293 |
| Kodiak Sciences | 130 |
| Aurinia Pharmaceuticals | 128 |
NKTR News
- 8 days ago - Nektar Therapeutics Transcript: AGM 2026 - Transcripts
- 9 days ago - Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 9 days ago - Nektar Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 16 days ago - Nektar Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference in New York - PRNewsWire
- 4 weeks ago - Nektar price target lowered to $80 from $95 at Wedbush - TheFly
- 5 weeks ago - Nektar price target raised to $192 from $105 at Piper Sandler - TheFly
- 5 weeks ago - Nektar Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 5 weeks ago - Nektar Therapeutics Earnings release: Q1 2026 - Filings